
Tattoo ink can migrate in female patients, potentially mimicking lymph node findings on breast imaging.

Tattoo ink can migrate in female patients, potentially mimicking lymph node findings on breast imaging.

Initial guidance advised these adenopathies would resolve within six weeks. Research and clinical experience shows it’s taking much longer.

The imaging industry has a role to play in bringing about change in screening.

Here's what to expect this week on Diagnostic Imaging.

Research findings show patient age and existing mammogram studies play a role in assessment.

AI-fueled mammography triage software from DeepHealth wins 510(k).

MD Anderson Cancer Center medical director shares her thoughts the priorities and challenges facing breast cancer detection and screening.

Patients want to know their risk. But, before you provide it, consider these factors to successfully integrate it into your practice.

Here's what to expect this week on Diagnostic Imaging.

Patients indicated breast imaging radiologists expressed more empathy over the diagnosis and had more understanding of their scans than other providers.

CEM performance showed no significant difference between women with or without breast implants, and it produced very few complications.

Despite recommendations from the American College of Radiology, most providers opt to delay screening in these women.

The screening mammography non-adherence rate among American Indian women is 1.5 times that of the overall population.

After a decade, roughly 75 percent of women with dense breasts seen in one department now undergo screening whole-breast ultrasound as a supplemental imaging service.

Images can pinpoint which women are at risk for ischemia and nipple necrosis.

More than 60 percent of news stories, including those discussing screening mammography, only highlight the potential benefits of testing.

Findings support argument for replacing digital mammography with digital breast tomosynthesis for breast cancer screening.

Here's what to expect this week on Diagnostic Imaging.

Impact felt the most in specialties with high screening rates, least in interventional radiology.

Fetal cardiac MRI and congenital heart defects; Survival tips for early radiology practice; Plus, Risk-based prioritization models for mammography during crises.

The latest products released on the market for Quarter 1 2021.

Here's what to expect this week on Diagnostic Imaging.

Chest X-ray and Chest CT for TB Detection; Contrast-Enhanced Mammography for Women with Breast Implants; Risk-Based Approach to Optimizing Mammography During Crisis; Plus, Natural Language Processing for COVID-19 Case Volume Prediction

Focusing on high-to-very high risk patients could provide the greatest cancer detection rate with the fewest exams during times of reduced capacity.

Findings show contrast-enhanced mammography is an acceptable option for women who may not have access to MRI or who cannot undergo the exam.